Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

1.

Role of inflammation in cognitive impairment: results of observational epidemiological studies and clinical trials.

Gorelick PB.

Ann N Y Acad Sci. 2010 Oct;1207:155-62. doi: 10.1111/j.1749-6632.2010.05726.x. Review.

PMID:
20955439
[PubMed - indexed for MEDLINE]
3.

[Hypertension in the elderly and risk of dementia].

Hanon O.

Rev Prat. 2010 May 20;60(5):649-53. French.

PMID:
20564847
[PubMed - indexed for MEDLINE]
4.

Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?

Karplus TM, Saag KG.

Drug Saf. 1998 Dec;19(6):427-33. Review.

PMID:
9880087
[PubMed - indexed for MEDLINE]
5.

Dietary fatty acids in dementia and predementia syndromes: epidemiological evidence and possible underlying mechanisms.

Solfrizzi V, Frisardi V, Capurso C, D'Introno A, Colacicco AM, Vendemiale G, Capurso A, Panza F.

Ageing Res Rev. 2010 Apr;9(2):184-99. doi: 10.1016/j.arr.2009.07.005. Epub 2009 Jul 28. Review.

PMID:
19643207
[PubMed - indexed for MEDLINE]
6.

Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence.

Szekely CA, Zandi PP.

CNS Neurol Disord Drug Targets. 2010 Apr;9(2):132-9. Review.

PMID:
20205647
[PubMed - indexed for MEDLINE]
7.

Clinical trials for preventing post stroke cognitive impairment.

Ankolekar S, Geeganage C, Anderton P, Hogg C, Bath PM.

J Neurol Sci. 2010 Dec 15;299(1-2):168-74. doi: 10.1016/j.jns.2010.08.052. Epub 2010 Sep 19.

PMID:
20855090
[PubMed - indexed for MEDLINE]
8.

[The possible suppression of Alzheimer's disease by nonsteroidal anti-inflammatory drugs].

de Jong D, Jansen RW, Verbeek MM, Kremer HP.

Ned Tijdschr Geneeskd. 2002 Nov 2;146(44):2074-8. Review. Dutch.

PMID:
12448960
[PubMed - indexed for MEDLINE]
9.

A substudy protocol of the hypertension in the Very Elderly Trial assessing cognitive decline and dementia incidence (HYVET-COG) : An ongoing randomised, double-blind, placebo-controlled trial.

Peters R, Beckett N, Nunes M, Fletcher A, Forette F, Bulpitt C.

Drugs Aging. 2006;23(1):83-92.

PMID:
16492072
[PubMed - indexed for MEDLINE]
10.
11.

Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms.

Panza F, Frisardi V, Capurso C, Imbimbo BP, Vendemiale G, Santamato A, D'Onofrio G, Seripa D, Sancarlo D, Pilotto A, Solfrizzi V.

J Alzheimers Dis. 2010;21(3):691-724. doi: 10.3233/JAD-2010-091669. Review.

PMID:
20571214
[PubMed - indexed for MEDLINE]
12.

Vascular risk factors, alcohol intake, and cognitive decline.

Panza F, Capurso C, D'Introno A, Colacicco AM, Frisardi V, Santamato A, Ranieri M, Fiore P, Vendemiale G, Seripa D, Pilotto A, Capurso A, Solfrizzi V.

J Nutr Health Aging. 2008 Jun-Jul;12(6):376-81. Review.

PMID:
18548174
[PubMed - indexed for MEDLINE]
13.

Non-steroidal anti-inflammatory drugs and cognitive function: are prostaglandins at the heart of cognitive impairment in dementia and delirium?

Cunningham C, Skelly DT.

J Neuroimmune Pharmacol. 2012 Mar;7(1):60-73. doi: 10.1007/s11481-011-9312-5. Epub 2011 Sep 20. Review.

PMID:
21932048
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Cardiovascular risk factors and dementia.

Fillit H, Nash DT, Rundek T, Zuckerman A.

Am J Geriatr Pharmacother. 2008 Jun;6(2):100-18. doi: 10.1016/j.amjopharm.2008.06.004. Review.

PMID:
18675769
[PubMed - indexed for MEDLINE]
15.

The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans.

Richards SS, Emsley CL, Roberts J, Murray MD, Hall K, Gao S, Hendrie HC.

J Am Geriatr Soc. 2000 Sep;48(9):1035-41.

PMID:
10983901
[PubMed - indexed for MEDLINE]
16.

Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia.

de Craen AJ, Gussekloo J, Vrijsen B, Westendorp RG.

Am J Epidemiol. 2005 Jan 15;161(2):114-20.

PMID:
15632261
[PubMed - indexed for MEDLINE]
Free Article
18.

Mild cognitive impairment.

Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B; International Psychogeriatric Association Expert Conference on mild cognitive impairment.

Lancet. 2006 Apr 15;367(9518):1262-70. Review.

PMID:
16631882
[PubMed - indexed for MEDLINE]
19.

Nutraceutical properties of Mediterranean diet and cognitive decline: possible underlying mechanisms.

Frisardi V, Panza F, Seripa D, Imbimbo BP, Vendemiale G, Pilotto A, Solfrizzi V.

J Alzheimers Dis. 2010;22(3):715-40. doi: 10.3233/JAD-2010-100942. Review.

PMID:
20858954
[PubMed - indexed for MEDLINE]
20.

Dietary fatty acids intake: possible role in cognitive decline and dementia.

Solfrizzi V, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Capurso S, Gadaleta A, Capurso A, Panza F.

Exp Gerontol. 2005 Apr;40(4):257-70. Review.

PMID:
15820606
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk